reports
- GlobalData Healthcare Department
Qurient Co Ltd (115180) - Financial Analysis Review
Qurient Co Ltd (115180) - Financial Analysis Review Summary Qurient Co Ltd (Qurient) is a biotechnology company that focuses on the development of new drugs for unmet medical needs. The company’s portfolio of pipeline products includes Q301, Q203, Q701, 5LO INH and CDK7 INH among others. The company is developing products for the treatment of atopic dermatitis; extensively drug-resistant tuberculosis (XDR)/multi drug resistant (MDR)/ totally drug resistant (TDR) tuberculosis (TB); asthama an...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.